DM may be characterized as type 1—autoimmune destruction of beta-islet pancreatic cells that produce insulin—or type 2, which is associated with tissue insulin resistance, central obesity, dysregulated adiposity, and eventual insulin production deficits. The gene discussed is INS; the disease is Abdominal obesity.